Morelli, M., Scarponi, C., Mercurio, L., Facchiano, F., Pallotta, S., Madonna, S., . . . Albanesi, C. (2018). Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis. J Immunol Res.

Morelli, Martina, Claudia Scarponi, Laura Mercurio, Francesco Facchiano, Sabatino Pallotta, Stefania Madonna, Giampiero Girolomoni, et Cristina Albanesi. "Selective Immunomodulation of Inflammatory Pathways in Keratinocytes By the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis." J Immunol Res 2018.

Morelli, Martina, et al. "Selective Immunomodulation of Inflammatory Pathways in Keratinocytes By the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis." J Immunol Res 2018.